807320-43-0 Usage
General Description
"Cis-1'-Oxo-spiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid" is a chemical compound with a complex and unique structure. It contains a spiro ring system with a cyclohexane and furo[3,4-c]pyridine moiety, as well as a carboxylic acid functional group. The cis-1'Oxo configuration indicates the position of a ketone group on the spiro ring system. cis-1'-Oxo-spiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid may have potential pharmaceutical or biological activities due to its intricate structure and functional groups. Its exact uses and properties would need to be further studied and determined through research and testing.
Check Digit Verification of cas no
The CAS Registry Mumber 807320-43-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,0,7,3,2 and 0 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 807320-43:
(8*8)+(7*0)+(6*7)+(5*3)+(4*2)+(3*0)+(2*4)+(1*3)=140
140 % 10 = 0
So 807320-43-0 is a valid CAS Registry Number.
807320-43-0Relevant articles and documents
Practical synthesis of a neuropeptide Y antagonist via stereoselective addition to a ketene
Iida, Takehiko,Satoh, Hiroki,Maeda, Kenji,Yamamoto, Yuhei,Asakawa, Ken-Ichi,Sawada, Naotaka,Wada, Toshihiro,Kadowaki, Chie,Itoh, Takahiro,Mase, Toshiaki,Weissman, Steven A.,Tschaen, Dave,Krska, Shane,Volante
, p. 9222 - 9229 (2005)
The synthesis of neuropeptide Y antagonist 1, currently under clinical investigation for the treatment of obesity, is described. The convergent synthesis from trans-spirolactone carboxylic acid intermediate 2a and aminopyrazole 3 is predicated on a stereo
